The common PARK8 mutation LRRK2G²⁰¹⁹S is not a risk factor for breast cancer in the absence of Parkinson's disease

J Neurol. 2013 Aug;260(8):2177-8. doi: 10.1007/s00415-013-7027-7. Epub 2013 Jul 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Breast Neoplasms / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Middle Aged
  • Mutation / physiology
  • Parkinson Disease / genetics*
  • Protein Serine-Threonine Kinases / genetics*
  • Risk Factors

Substances

  • Biomarkers
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases